Addressing Hypertriglyceridemia and Cardiovascular Risk in Diabetes
There is growing evidence that the addition of triglyceride-lowering medication and lifestyle changes may be valuable in diabetes management.
Cardiology
Automated Machine Learning Measures Cardiac Structural Changes Faster Than Humans, but With Similar Precision
Although the precision of automated machine learning (AML) for analysis of cardiac structures matches that of expert clinicians and medical trainees, AML systems are >100 times faster in measuring changes in left ventricular ejection fraction in several cardiovascular disease states.
The Changing Gender Breakdown of Internal Medicine
Study results showed that although the percentage of women in internal medicine residency programs increased, the number of those pursuing in subspecialty fellowships decreased.
Revised AAP Hypertension Guidelines Identify Obese Youth With High CV Risk
A significant number of overweight and obese young people who are classified as nonhypertensive by the European Society of Hypertension criteria have high blood pressure and increased cardiovascular risk, according to newer American Academy of Pediatrics guidelines.
AHA Reports Prescription Omega-3 Fatty Acids Lower Triglycerides
Prescription omega-3 fatty acids at a dosage of 4 g daily were found to be effective and safe for use as monotherapy or in combination for hypertriglyceridemia.
Proposed Decision Pathway for Admission Into Cardiac Intensive Care Units
Researchers propose a set of detailed criteria to aid practitioners in determining the appropriateness of CICU admissions stratified by goals of care, quality of care required, and risk for clinical deterioration.
Effect of Nutritional Supplements on Cardiovascular Disease in Adults
Certain nutritional supplements and dietary interventions may reduce the risk for some cardiovascular outcomes in adults; however, the overall effect of nutritional supplements on cardiovascular disease outcomes remains unclear.
AHA/HFS Release Scientific Statement on Concomitant Type 2 Diabetes and Heart Failure
The American Heart Association and Heart Failure Society released a joint scientific statement summarizing the effects of type 2 diabetes management on heart failure outcomes.
Cancer Death Rates Decreased While Heart Disease Deaths Increased
Cancer death rates declined for adults aged 45 to 64 years from 1999 to 2017, while heart disease death rates decreased to 2011 and then increased.
Novel Reversal Agent for Ticagrelor Gets FDA’s Breakthrough Therapy Designation
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to PB2452 (PhaseBio), an investigational reversal agent for ticagrelor.
Next post in Medicine
